GlobeNewswire by notified

FLSmidth to supply ball mills, SAG mills and thickener solutions to Southeast Asian copper-gold mine

Share

PRESS RELEASE

FLSmidth has been chosen to supply a range of mineral processing equipment for a large, established copper-gold mine in Southeast Asia.The equipment, some of the largest in the world, will allow the mine to increase its process capacity.

The order was booked in Q1 2022 and is valued at approximately DKK360 million.

Under the agreement, FLSmidth will supply both the mills and thickeners for the project. The equipment includes two gearless SAG mills and two gearless ball mills plus three CCD thickeners, two tailings thickeners and one filtrate thickener.

“This is a welcomed order as it underlines our leading position in the copper and gold mining arena when it comes to productivity and throughput. The order for SAG mills, ball mills and thickeners highlights our strength in both comminution and separation. As a key equipment provider, we will ensure optimised throughput and the efficient commissioning of the equipment in an environmentally friendly manner. We are now looking forward to helping the customer increase its capacity and production of copper, a key mineral in the clean energy transition,” comments Mikko Keto, Group CEO and Mining President at FLSmidth.


Contacts:

Investor Relations
Jannick Lindegaard Denholt, +45 21 69 66 57, jli@flsmidth.com
Therese Möllevinge, +45 41 37 16 38, tmo@flsmidth.com
Mikkel Johansen, +45 23 30 29 50, mjoh@flsmidth.com

Media Relations
Rasmus Windfeld, +45 40 44 60 60, rwin@flsmidth.com


About FLSmidth
FLSmidth provides sustainable productivity to the global mining and cement industries. We deliver market-leading engineering, equipment and service solutions that enable our customers to improve performance, drive down costs and reduce environmental impact. Our operations span the globe and we are close to ~10,100 employees, present in more than 60 countries. In 2021, FLSmidth generated revenue of DKK 17.6 billion. MissionZero is our sustainability ambition towards zero emissions in mining and cement by 2030. FLSmidth works within fully validated Science-Based Targets, our commitment to keep global warming below 1.5°C and to becoming carbon neutral in our own operations by 2030. www.flsmidth.com

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Ted Elvhage, Board member in Fingerprint Cards AB (publ), has sold shares due to private financial commitments19.5.2022 14:14:57 CEST | Press release

Ted Elvhage, Board member in Fingerprint Cards AB, has sold 975,000 shares in Fingerprints. “The reason for my sale of shares is private financial commitments. I have an unchanged strong belief in the company's future and plan to invest in Fingerprints again as soon as it is possible for me to do so,” comments Ted Elvhage. Link to PDMR transactions register. For further information, please contact: Investor Relations: +46(0)10-172 00 10, investrel@fingerprints.com Press: +46(0)10-172 00 20, press@fingerprints.com About Fingerprints Fingerprint Cards AB (Fingerprints) – the world’s leading biometrics company, with its roots in Sweden. We believe in a secure and seamless universe, where you are the key to everything. Our solutions are found in hundreds of millions of devices and applications, and are used billions of times every day, providing safe and convenient identification and authentication with a human touch. For more information visit our website, read our blog, and follow us on

GOGL – Q1 2022 Presentation19.5.2022 13:59:16 CEST | Press release

Please find enclosed the presentation of Golden Ocean Group Limited’s first quarter 2022 results for today’s webcast / conference call at 15:00 CET. Attend by Webcast: Use to the follow link prior to the webcast: https://edge.media-server.com/mmc/p/zgb9bp5w Attend by Conference Call: Applicable dial-in telephone numbers are as follows: International Dial-In: +44 (0) 2071 92 8338 United Kingdom Toll Free: 08002796619 Norway Toll Free: 800 56 865 US Toll-Free: +1 877 870 9135 The presentation material which will be used in the teleconference/webcast can be downloaded on www.goldenocean.bm and replay details will also be available at this website. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment Golden Ocean Q1 2022 - Presentation

Vow ASA: Minutes of Annual General Meeting19.5.2022 12:40:04 CEST | Press release

The annual general meeting of Vow ASA was held today on 19 May 2022 at the company's premises at Lysaker Torg 12, 1366 Lysaker, Norway. All matters on the agenda were approved, cf. the notice of the Annual General Meeting that was published on 28 April 2022. The complete minutes are attached to this release. For further information, please contact: Erik Magelssen, CFO, Vow ASA Tel: +47 928 88 728 Email: erik.magelssen@vowasa.com About Vow Vow and its subsidiaries Scanship, C.H. Evensen and Etia are passionate about preventing pollution. The company’s world leading solutions convert biomass and waste into valuable resources and generate clean energy for a wide range of industries. Cruise ships on every ocean have Vow technology inside which processes waste and purifies wastewater. Fish farmers are adopting similar solutions, and public utilities and industries use our solutions for sludge processing, waste management and biogas production on land. With advanced technologies and solution

Bavarian Nordic modtager vaccineordre fra europæisk land efter bekræftede tilfælde af abekopper19.5.2022 11:46:42 CEST | pressemeddelelse

KØBENHAVN, Danmark, 19. maj 2022 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har indgået en kontrakt med et unavngivet europæisk land vedrørende levering af koppevaccinen IMVANEX® i forbindelse med nye tilfælde af abekopper, der er identificeret i løbet af maj 2022. Det første europæiske tilfælde blev bekræftet den 7. maj 2022 hos en person, der vendte hjem fra en rejse til Nigeria, hvor abekopper er naturligt forekommende. Efterfølgende er der bekræftet mere end 20 tilfælde i England, Portugal og Spanien, og flere formodede tilfælde er ved at blive undersøgt. De fleste infektioner lader til at være sket lokalt i de tre lande. I USA er der bekræftet et enkelt tilfælde hos en rejsende fra Canada, hvor der endnu ikke foreligger bekræftede tilfælde, men adskillige formodede tilfælde er ved at blive undersøgt. Bavarian Nordics koppevaccine er godkendt i USA under navnet JYNNEOS® og i Canada under navnet IMVAMUNE®. I begge lande er godkendelsen udvidet til at omfatte abek

Bavarian Nordic Secures Vaccine Order from European Country After Confirmed Monkeypox Cases19.5.2022 11:46:42 CEST | Press release

COPENHAGEN, Denmark, May 19, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company has secured a contract with an undisclosed European country to supply its IMVANEX® smallpox vaccine in response to new cases of monkeypox evolving during May 2022. The first European case was confirmed on May 7, 2022, in an individual who returned from a travel to Nigeria, where monkeypox is endemic. Subsequently, more than 20 cases have been confirmed across England, Portugal and Spain with additional suspected cases currently being investigated. Evidence points to that most of the infections have been acquired locally in these countries. In the US, a single case has been confirmed in a traveler from Canada, where no cases are yet confirmed, but several remain under investigation. Bavarian Nordic’s smallpox vaccine is approved in the U.S. as JYNNEOS® and in Canada as IMVAMUNE®, both places with the approval extended to cover the monkeypox indication. The vaccine is approved in Europe a